A unique case of serous psammocarcinoma of the ovary presenting with pleural effusion and manifesting psammoma body implants in the pleural cavity and pericardium

Tiro, Aileen V.; Talukdar, Rubaiya; Lewis, Martin

doi:10.1016/j.ygyno.2009.03.008

Cited by 8 publications

(8 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All of the authors described elevation of CA 125 levels. In their article from 2009 Tiro et al presented a case of ovarian SPC with 175 U/ml [7]. The team suggested a correlation between the production of CA 125 tumour marker and the quantity of the calcifications.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Serous psammocarcinoma of the ovary: case report with systematic review

Mihaylov¹,

Yordanov²,

Strateva³

et al. 2021

View full text Add to dashboard Cite

Psammocarcinoma is a rare subtype of serous epithelian neoplasms arising from the ovaries and the peritoneum. It is characterized by massive psammoma body formation, low-grade cytological features, and invasiveness. We present a case of a 59-year-old female diagnosed with relapse of ovarian psammocarcinoma. She was operated 4 years previously and did not undergo chemotherapy. We performed a systematic search on this topic using the PubMed and ScienceDirect databases. In the literature 33 cases of ovarian psammocarcinoma are reported. We discuss the clinicopathological features of these patients. Ovarian psammocarcinoma is a rare and not well described disease. Due to the small number of cases found in the literature, no conclusions can be drawn about the tumour characteristics. StreszczeniePiaszczakorak jest rzadko występującym podtypem raka surowiczego wywodzącym się z nabłonka jajników i otrzewnej. Charakteryzuje się obecnością licznych ciałek piaszczakowatych, niskim stopniem złośliwości histologicznej oraz inwazyjnością. Przedstawiamy przypadek 59-letniej pacjentki, u której rozpoznano wznowę piaszczakoraka jajnika. Cztery lata wcześniej u chorej zastosowano leczenie chirurgiczne. Nie została poddana chemioterapii. Na potrzeby poniższej pracy dokonano przeglądu piśmiennictwa dotyczącego tego nowotworu, przeszukując bazy danych PubMed i ScienceDirect. Znaleziono łącznie 33 opisane przypadki piaszczakoraka jajnika. W artykule omówiono cechy kliniczno-patologiczne występujące u pacjentek z tym typem nowotworu. Piaszczakorak jajnika występuje rzadko i nie jest nowotworem dokładnie poznanym. Ze względu na niewielką liczbę przypadków opisanych w piśmiennictwie nie można wyciągnąć definitywnych wniosków dotyczących charakterystyki tego typu nowotworu.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The patient developed psammocarcinoma of the rectum 10 years after the treatment. Tiro et al described a patient with implants in the pleural cavity and the pericardium [7]. Poggi et al described the aggressive nature of the disease as highly metastatic [4].…”

Section: Discussionmentioning

confidence: 99%

Serous psammocarcinoma of the ovary: case report with systematic review

Mihaylov¹,

Yordanov²,

Strateva³

et al. 2021

View full text Add to dashboard Cite

show abstract

“…After reviewing previous reports, we found that 23 out of 26 patients bearing psammocarcinom of ovary were advanced at FIGO stage III-IV (88%), which indicates a trend similar to that of ovarian high-grade serous carcinoma. 1,[10][11][12][13][14][15][16][17][18][19][20][21][22] The survival rate is higher than that of high-grade serous carcinoma and is comparable to that of borderline malignant serous tumors, and the 5-year survival rate of patients at stage I has been reported to exceed 95%. 23,24 Even in advanced cases, the rate of recurrence is low, and in cases of recurrence, the progression is gradual and follows a long-term course.…”

Section: Discussionmentioning

confidence: 99%

Primary ovarian serous psammocarcinoma-a case report with mini literature review

Baba¹,

Fukagawa²,

Itamochi³

et al. 2020

OGIJ

View full text Add to dashboard Cite

Serous psammocarcinoma is a rare subtype of serous carcinoma in which a significant number of psammoma bodies are present histologically. Because it is an extremely rare disease, the pathogenesis of the disease remains unclear. Here we present a case of primary ovarian serous psammocarcinoma in which computed tomography (CT) imaging of the abdomen was useful for the diagnosis. A female patient was referred to our department with a complaint of abdominal distention. Pelvic magnetic resonance imaging revealed a multifocal tumor with a papillary enhancement in the right appendicular region, and abdominal CT imaging exhibited marked calcification of the enhancement. She underwent a laparotomy for suspected right ovarian cancer. As postoperative pathological examination revealed dominant stromal infiltration of psammoma bodies beneath peritoneum, this case was diagnosed as primary ovarian serous psammocarcinoma at FIGO Stage IIB. The patient was treated with six courses of paclitaxel plus carboplat in after the surgery. She is currently under outpatient observation without any signs of recurrence after 8 years of treatment. The case of significant calcification of the intra cystic enrichment on CT imaging is considered to be a case of this disease.

show abstract

“…It has also been exceptionally reported that ovarian adenocarcinoma could spread to extra-abdomen, such as the supra-clavicular space [13], pleural cavity, and pericardium [14]. When the calcified lesion presents in the region where ovarian metastases are rare occurrences, anatomic imaging can be very difficult in discrimination between calcified metastasis and old granulomatous disease.…”

Section: Discussionmentioning

confidence: 99%

Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases

Zhou

Zhang

2011

Abdom Imaging

View full text Add to dashboard Cite

Two cases of postoperative female patients with ovarian serous papillary carcinoma were referred for F-18 Fluorodeoxyglucose (F-18 FDG) PET/CT to evaluate suspicious recurrence and/or metastasis. One patient presented with multiple extensive calcified lesions with increased FDG uptake in the abdominopelvic cavity and the series of PET/CT scans showed progression of disease after chemotherapy. The other patient presented with three calcified masses with intensive uptake of FDG located in the left pelvis, the right subphrenic region, and the right supradiaphragmatic area, respectively. These suggest that F-18 FDG PET/CT can be useful in identifying malignant calcification and assessing therapeutic response of calcified malignancy.

show abstract

A unique case of serous psammocarcinoma of the ovary presenting with pleural effusion and manifesting psammoma body implants in the pleural cavity and pericardium

Cited by 8 publications

References 14 publications

Serous psammocarcinoma of the ovary: case report with systematic review

Serous psammocarcinoma of the ovary: case report with systematic review

Primary ovarian serous psammocarcinoma-a case report with mini literature review

Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases

Contact Info

Product

Resources

About